On January 3rd, Professor Zhou Yingjia, general secretary of the Party Committee of HBUT, and Doctor Liu Binlei, president of Wuhan Binhui Biotech Co. Ltd.(BBT), unveiled the HBUT-BBT R & D center and postgraduate workstation for biological treatment of tumor biotherapy at our university.
Based on the East Lake National Independent Innovation Model Area, BBT is a high-tech industrial biotechnology company with technical support from Wuhan Biotechnology Research Institute, Hubei University of Technology, and Hubei Institute of Science and Technology, which is engaged in the research, development and production of viral gene vectors.
